• Info
  • Insider Ownership

Insider Trading & Ownership of Matthew Gline

Location
New York, NY
Summary
The estimated net worth of Matthew Gline is at least $502M dollars as of 17 Dec 2025. Matthew Gline is the CEO, Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $375M. Matthew Gline is the Director, 10%+ Owner of Arbutus Biopharma Corp and owns shares of Arbutus Biopharma Corp (ABUS) stock worth about $128M.
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Matthew Gline
All Insider Reports
All Insider Reports

Notify me when Matthew Gline files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Matthew Gline

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ROIV Roivant Sciences Ltd. CEO, Director $375M -$37.7M -9.13% 15 Dec 2025
ABUS Arbutus Biopharma Corp Director, 10%+ Owner $128M 24 Feb 2025

Insider Transactions Reported by Matthew Gline:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.